Floatz logo

TEONANACATL

Depression, Bipolar

The University of Texas Health Science Center, HoustonSmall moleculePhase 2Active
CCC
53/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
38/ 100
Competitive Position
95/ 100

Competitive context

4 Active assets in the Depression, Bipolar cohort.

Asset / SponsorPhaseRating
Olanzapine
China Medical University, China
Phase 4BBB
ZIPRASIDONE
Queen's University
Phase 4BBB
Cariprazine
Aalborg University Hospital
Phase 4BB
Valproic Acid
Ewha Womans University Mokdong Hospital
Phase 4BB
Starch
China Medical University, China
Phase 4BB

View all 23 →

Same molecule, other indications

TEONANACATL is also rated in:

major depressive disorderDormant
BB
Indicative ·
70 / 100
View asset →
depressive disorderDormant
BB
Indicative ·
69 / 100
View asset →
bipolar II disorderDormant
BB
Indicative ·
66 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →